Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY - Get Free Report)'s share price gapped down before the market opened on Friday . The stock had previously closed at $8.57, but opened at $8.27. Shionogi & Co., Ltd. Unsponsored ADR shares last traded at $8.27, with a volume of 954 shares.
Shionogi & Co., Ltd. Unsponsored ADR Stock Performance
The company has a quick ratio of 6.13, a current ratio of 6.63 and a debt-to-equity ratio of 0.01. The company has a market capitalization of $14.53 billion, a PE ratio of 14.61, a PEG ratio of 1.97 and a beta of 0.18. The firm has a 50-day moving average of $8.22 and a two-hundred day moving average of $7.62.
Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY - Get Free Report) last released its quarterly earnings results on Monday, May 12th. The company reported $0.14 earnings per share for the quarter, missing analysts' consensus estimates of $0.17 by ($0.03). The company had revenue of $721.77 million during the quarter, compared to the consensus estimate of $824.23 million. Research analysts anticipate that Shionogi & Co., Ltd. Unsponsored ADR will post 0.66 EPS for the current year.
Shionogi & Co., Ltd. Unsponsored ADR Company Profile
(
Get Free Report)
Shionogi & Co, Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan. It offers Fetroja, a multidrug-resistant for gram-negative bacterial infection treatment; Cabenuva and Apretude an anti-HIV and HIV prophylactic drug; Xocova an oral COVID-19 treatment drug; Finibax a carbapenem antibiotic; Xofluza, an influenza antiviral drug; and Tivicay, an anti-HIV drug.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Shionogi & Co., Ltd. Unsponsored ADR, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Shionogi & Co., Ltd. Unsponsored ADR wasn't on the list.
While Shionogi & Co., Ltd. Unsponsored ADR currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
